EAM
TCBPW

Empery Asset Management’s TC BioPharm (Holdings) plc Warrants TCBPW Stock Holding History

Empery Asset Management’s Portfolio TCBPW Stock Details TCBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$653K Hold
2,823,528
– – 3.89% 8
2022
Q2 		$571K Hold
2,823,528
– – 3.09% 9
2022
Q1 		$1.38M Buy
+2,823,528
New +$1.31M 6.5% 2

Other funds holding TCBPW

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Empery Asset Management's TCBPW Position: Q3 2022 in Review

Empery Asset Management held its TC BioPharm (Holdings) plc Warrants (TCBPW) position steady in Q3 2022 at 2,823,528 shares worth $653K. The position accounts for 3.89% of the portfolio, ranked #8.

Empery Asset Management first reported a position in TCBPW in Q1 2022 and has held it in 3 quarters since. The position peaked at $1.38M in Q1 2022. 7 funds tracked by Wall St. Rank hold TCBPW as of Q3 2022.

  • Empery Asset Management held 2,823,528 shares of TC BioPharm (Holdings) plc Warrants worth $653K as of Q3 2022.
  • Empery Asset Management left its TC BioPharm (Holdings) plc Warrants share count unchanged in Q3 2022.
  • TC BioPharm (Holdings) plc Warrants made up 3.89% of Empery Asset Management's portfolio in Q3 2022, its #8 holding.
  • Empery Asset Management first reported a position in TC BioPharm (Holdings) plc Warrants in Q1 2022 and has held it in 3 quarters since.
  • Empery Asset Management's TC BioPharm (Holdings) plc Warrants position peaked at $1.38M in Q1 2022.
  • 7 funds tracked by Wall St. Rank held TC BioPharm (Holdings) plc Warrants as of Q3 2022.

Based on Empery Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.